2019 International Congress Archives - Page 130 of 217

Validation of a novel quotient differentiating cognitive and motor-driven activity of daily living impairments in PD patients

S. Becker, C. Pauly, M. Lawton, G. Hipp, F. Bowring, P. Sulzer, M. Hu, R. Krüger, I. Liepelt-Scarfone (Tübingen, Germany)
Validation of Acoustic Analysis of Swallowing as a Method of Screening for Orofaringeal Dysfunction at Parkinson

RSS. Santos, BSZ. Zeigelboim, GSS. Silva, MCN. Nunes, HGT. Teive (Curitiba, Brazil)
Validation of the ‘ecological momentary assessment’ (EMA) method as a tool for daily life monitoring in patients with Parkinson’s disease

J. Habets, M. Heijmans, C. Herff, C. Simons, A. Leentjens, Y. Temel, M. Kuijf, P. Kubben (Maastricht, Netherlands)
Validation of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson’s Disease

J. Rick, S. Xie, E. Mamikonyan, B. Deck, S. Rudovsky, A. Chen-Plotkin, N. Dahodwala, J. Morley, J. Duda, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)
Validation of the diagnostic criteria for progressive supranuclear palsy in pathologically confirmed patients

I. Aiba, Y. Saito, Y. Yokokawa, T. Katayama, M. Kenjo, R. Hashimoto, S. Sakakibara, M. Sato, H. Nakatsuji, A. Inukai, Y. Iwasaki, M. Mimuro, A. Akagi, M. Yoshida (Nagoya, Japan)
Validation of the Hebrew version of the Unified Dyskinesia Rating Scale (UDysRS)

A. Socher, A. Thaler, H. Shabtai, J. Zitser, T. Shainer, M. Kestenbaum, A. Rosenberg, A. Bar David, A. Ezra, T. Taichman, M. Brozgol, T. Herman, G. Stebbins, C. Goetz, S. Luo, P. Martinez-Martin, N. Giladi, T. Gurevich (Mdrid, Spain)
Validation of the Movement Disorder Society criteria for the diagnosis of 4R-tauopathies

G. Respondek, MJ. Grimm, I. Piot, T. Arzberger, Y. Compta, E. Englund, LW. Ferguson, E. Gelpi, A. Giese, S. Roeber, DJ. Irwin, WG. Meissner, C. Nilsson, A. Pantelyat, A. Rajput, JB. Rowe, JC. van Swieten, C. Troakes, GU. Höglinger (London, United Kingdom)
Validation of the PREDIGT Score for the Incidence Rate of Parkinson disease

J. Li, T. Mestre, J. Tomlinson, M. Frasier, E. Lang, B. Mollenhauer, T. Ramsay, D. Manuel, M. Schlossmacher (Goettingen, Germany)
Validation of the Seoul-instrumental activity daily living in the detection of dementia in Parkinson disease

SJ. Kim (Busan, Republic of Korea)
Variants in the beta-Glucocerebrosidase A (GBA) gene in German patients with Parkinson´s disease

A. Deutschlander, A. Wernick, R. Walton, A. Soto, O. Ross, Z. Wszolek (Jacksonville, FL, USA)
Variations in Olfactory Neural Connections Associated with Cognition in Parkinson’s Disease

H. Chatterjee, G. Elumalai, N. Osakwe, N. Sewram (Georgetown, Guyana)
Vascular Parkinsonism and Parkinson’s Disease: clinical differences concerning balance impairment

R. Jesus, R. Raimundo, C. Azoia, M. Mendes, V. Espirito-Santo, A. Almeida, I. Rego, AG. Velon (Vila Real, Portugal)
Vascular risk factors and depression in multiple system atrophy

LY. Zhang, B. Cao, QQ. Wei, RW. Ou, HF. Shang (Chengdu, China)
Vascular risk factors, WMLs and the risk of cognitive impairment in Parkinson disease: A longitudinal study from the Parkinson’s Disease Cognitive Impairment Study (PaCoS) cohort

A. Luca, R. Monastero, G. Donzuso, R. Baschi, C. Cicero, C. Terravecchia, A. Salerno, M. Zuccarello, M. Davì, V. Restivo, G. Mostile, M. Zappia, A. Nicoletti (Catania, Italy)
Vascular white matter involvement in Idiopathic Normal Pressure Hydrocephalus: association with cognitive and motor impairment

M. Todisco, P. Vitali, B. Minafra, F. Avantaggiato, R. Zangaglia, NG. Pozzi, R. Ceravolo, C. Pacchetti (Pavia, Italy)
Verbal Disfluencies in Parkinson´s Disease Spoken Discourse as a Function of Syntax Complexity

S. Gutierrez, K. Aveni, A. Torani, A. Roberts (Evanston, IL, USA)
Vertebral pain and bone mineral density in women with Parkinson’s disease

I. Karaban, V. Povoroznyuk, M. Bystrytska, N. Karasevich, N. Grygorieva (Kyiv, Ukraine)
VIM stimulation for refractory tremor -the Sheba experience

V. Livneh, S. Korn, G. Yaalom, T. Karmon, H. Strauss, Z. Zibly, R. Spiegelmann, S. Baer (Tel Aviv, Israel)
Virtual Reality EEG guided motor neurofeedback training has mid-term effects in Parkinson’s Disease Patients limits of stability

JP. Romero, A. Arroyo, J. Andreo, M. Del Castillo, J. Serrano, E. Rocon, N. Malpica, E. Melero, M. Gil, E. Sanz, P. Serrano, E. Rodriguez (Madrid, Spain)
Visual assessment of dopamine transporter imaging in normal pressure hydrocephalus

KY. Kwon, H. Ju, K. Im, JY. Lee, MY. Ahn (Seoul, Republic of Korea)
Visual dysfunction and retinal thinning predict dementia risk in Parkinson’s disease

L-A. Leyland, F. Bremner, R. Mahmood, S. Hewitt, M. Durteste, M. Cartlidge, M. Lai, L. Miller, A. Saygin, P. Keane, A. Schrag, R. Weil (London, United Kingdom)
Visual evoked potentials alterations in DLB

C. Carrarini, M. Russo, F. Anzellotti, F. Dono, S. Nanni, M. Onofrj, L. Bonanni (Chieti, Italy)
Visual hallucinations in Lewy Body Disease are characterised by impaired sensory integration

A. Zarkali, R. Adams, L. Leyland, G. Rees, R. Weil (London, United Kingdom)
Visual hallucinations in Parkinson´s disease and amyloid burden: 18F-Flutemetamol PET-MRI study

B. Fernández-Rodríguez, C. Gasca-Salas, R. Rodríguez-Rojas, P. Guida, D. Mata-Marín, I. Obeso-Martín, L. Vela, M. Garcerant-Tafur, L. García-Cañamaque, JA. Obeso (Móstoles, Spain)
Visual sensory processing is altered in myoclonus dystonia

C. Clement, N. Nicolas, C. Cécile, E. Eavan, R. Romain, M. Marie, P. Pierre, E. Emmanuel, Y. Yulia (Paris, France)
Visual subnetwork dysfunction in Parkinson’s patients with primary visual hallucinations

S. Rane, A. Lenka, S. Prasad, J. Saini, M. Ingalhalikar, P. Pal (Seatle, WA, USA)
Visuoperceptual impairment: a key feature in the diagnosis of corticobasal degeneration

R. Bruffaerts, K. van Bouwel, PH. van Damme, K. Claeys, K. van Laere (Leuven, Belgium)
Visuospatial dysfunction correlates with severity of postural instability/gait disturbance symptoms in parkinson’s disease

H. Jeong, H. Kang (Changwon, Republic of Korea)
Vocal cords electromyography abnormalities in multiple system atrophy phenotypes: relevance for the pathophysiology of stridor

M. Todisco, E. Alfonsi, I. Isaias, R. Zangaglia, B. Minafra, M. Terzaghi, N. Pozzi, C. Pacchetti (Pavia, Italy)
Vortioxetine treatment of depression in Parkinson’s disease

M. Russo, C. Carrarini, F. Dono, L. Ferri, M. Di Pietro, M. Onofrj (Chieti, Italy)